Privium Fund Management’s Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 HLGN.WS Stock Holding History

Privium Fund Management’s Portfolio HLGN.WS Stock Details HLGN.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-133,249	Closed	-$7.33K	–	159
2022 Q4	$7.33K	Sell	133,249 -217,772	-62%	-$29.7K	﹤0.01%	112
2022 Q3	$80K	Sell	351,021 -279,128	-44%	-$76.7K	0.03%	122
2022 Q2	$166K	Sell	630,149 -24,975	-4%	-$14.8K	0.06%	112
2022 Q1	$806K	Buy	+655,124	New	+$638K	0.18%	70

Other funds holding HLGN.WS

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

ICM

Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $8.09B AUM 21.95% 1-Year Est. Return

Privium Fund Management's HLGN.WS Position: Q1 2023 in Review

Privium Fund Management sold out of Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) in Q1 2023, closing a stake of 133,249 shares — an estimated $7.33K sold.

Privium Fund Management first reported a position in HLGN.WS in Q1 2022 and held it in 4 quarters. The position peaked at $806K in Q1 2022. 17 funds tracked by Wall St. Rank hold HLGN.WS as of Q1 2023.

Privium Fund Management reported no remaining Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position as of Q1 2023 after selling out during the quarter.
Privium Fund Management sold 133,249 Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 shares in Q1 2023, an estimated $7.33K.
Privium Fund Management first reported a position in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in Q1 2022 and held it in 4 quarters.
Privium Fund Management's Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position peaked at $806K in Q1 2022.
17 funds tracked by Wall St. Rank held Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 as of Q1 2023.

Based on Privium Fund Management's 13F filing for Q1 2023, filed 3 May 2023.